USage of chitosan for Femoral (USF) haemostasis after percutaneous procedures: A comparative open label study

EuroIntervention

Volumn 6, Issue 9, 2011, Pages 1104-1109

  Arbel, Joel ^a   Rozenbaum, Eliezer ^a   Reges, Orna ^a   Neuman, Yoram ^a   Levi, Alex ^a   Erel, Jacob ^a   Haskia, Abdel R ^a   Caneti, Menachem ^a   Sherf, Michael ^b   Mosseri, Morris ^a  

^a MEIR MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Chitosan; Coronary angiography; Haemostasis; Vascular access

Indexed keywords

ACETYLSALICYLIC ACID; CHITOSAN; CLOPIDOGREL; HEPARIN; PLACEBO; HEMOSTATIC AGENT;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY CATHETERIZATION; ARTERY COMPRESSION; ARTICLE; BLEEDING; BLOOD CLOTTING TIME; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FEMORAL ARTERY; HEMATOMA; HEMOSTASIS; HUMAN; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; OPEN STUDY; PATIENT SATISFACTION; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL; TIME; BLOOD; CATHETERIZATION; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ISRAEL; MIDDLE AGED; PRESSURE; PUNCTURE; TREATMENT OUTCOME;

AGED; CATHETERIZATION, PERIPHERAL; CHI-SQUARE DISTRIBUTION; CHITOSAN; CORONARY ANGIOGRAPHY; FEMALE; FEMORAL ARTERY; HEMATOMA; HEMORRHAGE; HEMOSTATIC TECHNIQUES; HEMOSTATICS; HUMANS; ISRAEL; MALE; MIDDLE AGED; PRESSURE; PUNCTURES; TIME FACTORS; TREATMENT OUTCOME;

EID: 80051639946     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV6I9A192     Document Type: Article

References (36)

1. Baim DS, Grossman W. Complications of cardiac catheterization. In: Cardiac Catheterization, Angiography and Intervention, Baim, DS, Grossman, W (Eds), Williams & Wilkins, Baltimore 1996. p.17.
2. Nikolsky E, Mehran R, Halkin A, Aymong ED, Mintz GS, Lasic Z, Negoita M, Fahy M, Krieger S, Moussa I, Moses JW, Stone GW, Leon MB, Pocock SJ, Dangas G. Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol. 2004;44:1200-1209. (Pubitemid 39208874)
3. Geary K, Landers JT, Fiore W, Riggs P. Management of infected femoral closure devices. Cardiovasc Surg. 2002;10:161-163. (Pubitemid 34223440)
4. Cherr GS, Travis JA, Ligush J Jr, Plonk G, Hansen KJ, Braden G, Geary RL. Infection is an unusual but serious complication of a femoral artery catheterization site closure device. Ann Vasc Surg. 2001;15:567-570. (Pubitemid 32937776)
5. Wedmore I, McManus JG, Pustareti AE, Holcomb JB. A special report on the chitosan-based hemostatic dressing: Experience in current combat operations. J Trauma. 2006;60:655-658.
6. Steinhubl SR, Kastrati A, Berger PB. Variation in the definitions of bleeding in clinical trials of patients with acute coronary syndromes and undergoing percutaneous coronary interventions and its impact on the apparent safety of antithrombotic drugs. Am Heart J. 2007;154:3-11. (Pubitemid 46924806)
7. Johnson LW, Lozner EC, Johnson S, Krone R, Pichard AD, Vetrovec GW, Noto TJ. Coronary angiography 1984-7: A report of the registry of the Society for Cardiac Angiography and Interventions I. Results and complications. Cathet Cardiovasc Diagn. 1989;17:5-10. (Pubitemid 19112841)
8. Hamon M, Baron JC, Viader F, Hamon M. Periprocedural stroke and cardiac catheterization. Circulation. 2008;118:678-683.
9. Dorros G, Cowley MJ, Simpson J, Bentivoglio LG, Block PC, Bourassa M, Detre K, Gosselin AJ, Grüntzig AR, Kelsey SF, Kent KM, Mock MB, Mullin SM, Myler RK, Passamani ER, Stertzer SH, Williams DO. Percutaneous transluminal coronary angioplasty: Report of complications from the National Heart, Lung, and Blood Institute PTCA registry. Circulation. 1983;67:723-730. (Pubitemid 13161448)
10. Kennedy JW. Complications associated with cardiac catheterization and angiography. Cathet Cardiovasc Diagn. 1982;8:5-11. (Pubitemid 12106612)
11. Noto TJ, Johnson LW, Krone R, Weaver WF, Clark DA, Kramer JR Jr, Vetrovec GW. Cardiac catheterization 1990: A report of the registry of the Society for Cardiac Angiography and Interventions. Cathet Cardiovasc Diagn. 1991;24:75-83.
12. Laskey W, Boyle J, Johnson LW. Multivariable model for prediction of risk of significant complication during diagnostic cardiac catheterization. The Registry Committee of the Society for Cardiac Angiography &Interventions. Cathet Cardiovasc Diagn. 1993;30:185-190. (Pubitemid 23320266)
13. Wyman RM, Safian RD, Portway V, Skillman JJ, McKay RG, Baim DS. Current complications of diagnostic and therapeutic cardiac catheterization. J Am Coll Cardiol. 1988;12:1400-1406.
14. King KM, Ghali WA, Faris PD, Curtis MJ, Galbraith PD, Graham MM, Knudtson ML. Sex differences in outcomes after cardiac catheterization: effect modification by treatment strategy and time. JAMA. 2004;291:1220-1225. (Pubitemid 38541665)
15. Hemmelgarn BR, Southern DA, Humphries KH, Culleton BF, Knudtson ML, Ghali WA. Refined characterization of the association between kidney function and mortality in patients undergoing cardiac catheterization. Eur Heart J. 2006;27:1191-1197.
16. Omran H, Schmidt H, Hackenbroch M, Illien S, Bernhardt P, von der Recke G, Fimmers R, Flacke S, Layer G, Pohl C, Lüderitz B, Schild H, Sommer T. Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study. Lancet. 2003;361:1241-1246. (Pubitemid 36428577)
17. El-Jack SS, Ruygrok PN, Webster MW, Stewart JT, Bass NM, Armstrong GP, Ormiston JA, Pornratanarangsi S. Effectiveness of manual pressure hemostasis following transfemoral coronary angiography in patients on therapeutic warfarin anticoagulation. Am J Cardiol. 2006;97:485-488. (Pubitemid 43190036)
18. Pracyk JB, Wall TC, Longabaugh JP, Tice FD, Hochrein J, Green C, Cox G, Lee K, Stack RS, Tcheng JE. A randomized trial of vascular hemostasis techniques to reduce femoral vascular complications after coronary intervention. Am J Cardiol. 1998;81:970-976. (Pubitemid 28183661)
19. Ward SR, Casale P, Raymond R, Kussmaul WG 3rd, Simpfendorfer C. for the Angio-Seal Investigators. Efficacy and safety of a hemostatic puncture closure device with early ambulation after coronary angiography. Am J Cardiol. 1998;81:569-572. (Pubitemid 28182419)
20. Kapadia SR, Raymond R, Knopf W, Jenkins S, Chapekis A, Ansel G, Rothbaum D, Kussmaul W, Teirstein P, Reisman M, Casale P, Oster L, Simpfendorfer C. The 6Fr Angio-Seal arterial closure device: results from a multimember prospective registry. Am J Cardiol. 2001;87:789-791. (Pubitemid 32209102)
21. Silber S, Gershony G, Schön B, Schön N, Jensen T, Schramm W. A novel vascular sealing device for closure of percutaneous arterial access sites. Am J Cardiol. 1999;83:1248-1252. (Pubitemid 29183926)
22. Silber S, Tofte AJ, Kjellevand TO, Grube E, Gershony G. Final report of the European multi-center registry using the Duett vascular sealing device. Herz. 1999;24:620-623. (Pubitemid 30030075)
23. Baim DS, Knopf WD, Hinohara T, Schwarten DE, Schatz RA, Pinkerton CA, Cutlip DE, Fitzpatrick M, Ho KK, Kuntz RE. Suture-mediated closure of the femoral access site after cardiac catheterization: results of the suture to ambulate and discharge (STAND I and STAND II) trials. Am J Cardiol. 2000;85:864-869. (Pubitemid 30157854)
24. Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Santos RM, Little WC. Propensity score analysis of vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention 1998-2003. Catheter Cardiovasc Interve. 2006;67:556-562.
25. Arora N, Mathney ME, Sepke C, Resnic FS. A propensity analysis of the risk of vascular complications after cardiac catheterization procedures with the use of closure devices. Am Heart J. 2007;153:606-611. (Pubitemid 46440677)
26. Narins CR, Zareba W, Rocco V, McNitt S. A prospective randomized trial of topical hemostasis patch use following percutaneous coronary and peripheral intervention. J Invasive Cardiol. 2008;20:579-584.
27. Chou TC, Fu E, Wu CJ, Yeh JH. Chitosan enhances platelet adhesion and aggregation. Biochem Biophys Res Comm. 2003;302:480-483. (Pubitemid 36279554)
28. Fischer TH, Bode AP, Demcheva M, Vournakis JN. Hemostatic properties of glucosamine-based materials. J Biomed Materials Res. 2007;80A:167-174. (Pubitemid 44913344)
29. Gustafson SB, Fulkerson P, Bildfell R, Aguilera L, Hazzard TM. Chitosan dressing provides hemostasis in swine femoral arterial injury model. Prehospital emergency care. 2007;11:172-178. (Pubitemid 46514905)
30. Pausateri AE, McCarthy SG, Gregory KW, Harris RA, Cardenas L, McManus AT, Goodwin CW Jr. Effect of chitosan-based hemostatic dressing on blood loss and survival in a model of severe venous hemorrhage and hepatic injury in swine. J Trauma. 2003;54:177-182. (Pubitemid 36113244)
31. Acheson EA, Kheirabadt BS, Deguzman R, Dick EJ Jr, Holcomb JB. Comparison of hemorrhage control agents applied to lethal extremity arterial hemorrhages in swine. J. Trauma. 2005: 59: 865-875. (Pubitemid 43048701)
32. Alam HB, Burris D, DaCorta JA, Rhee P. Hemmorrhage control in the battlefield: Role of new hemostatic agents. Military Med. 2005;170:63-69. (Pubitemid 40731920)
33. Pustareti AE, Holcomb JB, Kheirabadi BS, Alam HB, Wade CE, Ryan KL. Making sense of the preclinical literature on advanced hemostatic products. J Trauma. 2006;60:674-682.
34. Kheirabadi BS, Pausateri AE. Development of hemostatic dressings for use in military operations. Paper presented at the RTO HFM Symposium on "combat casualty care in ground based tactical situations: Trauma technology and emergency medical procedures", held in St. Pete Beach, USA, 16-18 August 2004, and published in RTO-MP-HFM-109.
35. Bachtell N, Goodell T, Grunkemeier G, Jin R, Gregory K. Treatment of dialysis access puncture wound bleeding with chitosan dressing. Dialysis & transplantation. 2006;35:672-681.
36. Nader RG, Gracia JC, Drushal K, Pesek T. Clinical evaluation of SyvekPatch in patients undergoing interventional, EPS and diagnostic cardiac catheterization procedures. J Invasive Cardiol. 2002;14:305-307. (Pubitemid 34651237)